CLOs on the Move

Mazor Robotics

www.mazorrobotics.com

 
Mazor Robotics Renaissance Guidance System is transforming spine surgery from freehand operations to highly-accurate, state-of-the-art procedures that may reduce fluoroscopy. It is the only mechanical guidance system for spine surgery with FDA clearance and CE marking. Renaissance has been used in thousands of spine procedures worldwide ranging from minimally-invasive surgery to scoliosis and other complex spinal deformity cases.
  • Number of Employees: 0-25
  • Annual Revenue: $0-1 Million

Executives

Name Title Contact Details

Similar Companies

Reva Medical

Founded in 1998, REVA Medical is dedicated to developing minimally invasive medical devices that leverage its proprietary biomaterial and stent technologies to improve the treatment of coronary artery disease. Guided by an executive management team and scientific advisors with extensive product development and clinical interventional cardiology experience, REVA’s initial focus is the development of a drug-eluting bioresorbable coronary scaffold to advance the treatment of cardiovascular disease, the leading cause of death worldwide.

Oasis Medical

Oasis Medical is a Glendora, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

General Devices

GD improves healthcare by developing the most comprehensive, interactive and widely-used mobile telemedicine, communication, and notification solutions for pre-hospital and hospital environments. Our affordable and completely customizable offerings empower EMS and medical teams to enhance workflows, and document, record and analyze interactions and patient data to minimize risk, reduce costs, and improve patient outcomes.

iCRco

iCRco is one of the leading companies in the Healthcare, Pharmaceuticals, & Biotech sector.

Corvia Medical

Corvia Medical, Inc. is revolutionizing the treatment of heart failure with a novel transcatheter structural heart device. Founded in 2009 and headquartered in Tewksbury, MA, Corvia Medical is dedicated to transforming the standard of care for heart failure treatment, enabling patients to reclaim their lives.